SCHEMBL30987690

SCHEMBL30987690

Cc1c(C(=O)O)sc2[nH]cnc(=O)c12

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BCAT2 O15382 6/20 0.60
HPGD P15428 5/20 0.44
LMNA P02545 3/20 0.44
KDM4E B2RXH2 3/20 0.41
GAA P10253 1/20 0.41
BLM P54132 1/20 0.40
ALDH1A1 P00352 2/20 0.40
POLB P06746 1/20 0.40
HTT P42858 1/20 0.38
PDPK1 O15530 1/20 0.37
THRB P10828 2/20 0.36
HSD17B10 Q99714 1/20 0.36
GPR35 Q9HC97 1/20 0.36
MAPT P10636 3/20 0.36
GABRR1 P24046 1/20 0.36
TP53 P04637 1/20 0.36
MKNK1 Q9BUB5 1/20 0.35
MKNK2 Q9HBH9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30987724 0.86 BCAT2 (0.44) BCAT2HPGDLMNAKDM4EGAA
SCHEMBL6004291 0.78 PDPK1 (0.54) BCAT2HPGDLMNAKDM4EGAA
SCHEMBL263739 0.75 BCAT2 (1.00) BCAT2HPGDLMNAKDM4EGAA
SCHEMBL1101885 0.69 TSHR (0.44) BCAT2HPGDLMNAKDM4EGAA
SCHEMBL9852516 0.65 PDPK1 (0.46) GAAALDH1A1PDPK1MAPT
SCHEMBL1621900 0.65 BCAT2 (0.41) BCAT2HPGDLMNAKDM4EGAA
SCHEMBL2804151 0.63 GPR35 (0.45) BCAT2HPGDLMNAKDM4EGAA
SCHEMBL27271781 0.62 PDPK1 (0.37) BCAT2HPGDLMNAKDM4EALDH1A1
SCHEMBL2808132 0.62 GPR35 (0.52) BCAT2HPGDLMNAKDM4EGAA
SCHEMBL19119395 0.61 BCAT2 (0.76) BCAT2HPGDLMNAKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4676929-A1 PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 Dark Blue Therapeutics Ltd (GB) 2026-01-14 EP disclosed
EP-4638447-A1 IMIDAZO[1,2-A]PYRIDINE AND IMIDAZO[1,2-A]PYRAZINE DERIVATIVES AS MLLT1 AND MLLT3 INHIBITORS Dark Blue Therapeutics Ltd (GB) 2025-10-29 EP disclosed
WO-2024188906-A1 PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 DARK BLUE THERAPEUTICS LTD (GB) 2024-09-19 WO disclosed
WO-2024133560-A1 IMIDAZO[1,2-A]PYRIDINE AND IMIDAZO[1,2-A]PYRAZINE DERIVATIVES AS MLLT1 AND MLLT3 INHIBITORS DARK BLUE THERAPEUTICS LTD (GB) 2024-06-27 WO disclosed